Life Biosciences

📍 Boston, United States🗓 Founded 2017👥 22 employees💰 Last funded Nov 2024
Biotechnology🌐 lifebiosciences.com
Website LinkedIn
Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical unmet needs.
3
Total investors
1
Early stage
1
Mid stage
1
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
China
1
Investor activity2017–2024 · investors recorded per year
201712021120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Life Biosciences?
Life Biosciences has 3 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Life Biosciences last raise funding?
The most recent investment in Life Biosciences recorded on gritt.io was in November 2024.
When was Life Biosciences founded?
Life Biosciences was founded in 2017.
What industry is Life Biosciences in?
Life Biosciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Life Biosciences based?
Life Biosciences is headquartered in Boston, United States.